Natural killer cells and recognition of MHC class I molecules: New perspectives and challenges in immunology

Scandinavian Journal of Immunology

Volumn 47, Issue 5, 1998, Pages 412-425

  Rolstad, B ^a,b   Seaman, W E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CELL RECEPTOR; CELL SURFACE MARKER; FC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CELL FUNCTION; GENE CLUSTER; GENE MAPPING; IMMUNE RESPONSE; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MICE; RATS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0031747208     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00358.x     Document Type: Review

References (179)

1. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112-7.
2. Bennett M. Biology and genetics of hybrid resistance. Adv Immunol 1987;41:333-445.
3. Rolstad B, Fossum S. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC. Immunology 1987;60:151-7.
4. Ciccone E, Viale O, Pende D, Malnati M, Biassoni R, Melioli G, Moretta A, Long EO, Moretta L. Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture. J Exp Med 1988;168:2403-8.
5. Chadwick BS, Miller RG. Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol 1992;148:2307-13.
6. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
7. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse GD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-62.
8. Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science 1990;249:1298-300.
9. Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol 1992;149:1631-5.
10. Fitzgerald-Bocarsly P, Herberman RB et al. A definition of natural killer cells. Immunol Today 1988;9:292.
11. van den Brink MRM, Palomba ML, Basse PH, Hiserodt JC. In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats. Cancer Res 1991;51:4931-6.
12. Rolstad B, Herberman RB, Reynolds CW. Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL) granular lymphocytes (LGL). J Immunol 1986;136:2800-8.
13. Vaage JT, Reynolds CW, Reynolds D, Fossum S, Rolstad B. The proliferation and life-span of rat large granular lymphocytes: effects of cytokines. Eur J Immunol 1989;19:1895-902.
14. Whitelaw PF, Croy BA. Granulated lymphocytes of pregnancy. Placenta 1996;17:533-43.
15. Rodewald H-R, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL. A population of early fetal thymocytes expressing FctRII/III contains precursors of T lymphocytes and natural killer cells. Cell 1992;69:139-50.
16. Sánchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T/Natural Killer cell progenitor in human fetal thymus. J Exp Med 1994;180:569-76.
17. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today 1992;13:392-5.
18. Sánchez MJ, Spits H, Lanier LL, Phillips JH. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J Exp Med 1993;178:1857-66.
19. Reynolds CW, Sharrow SO, Ortaldo JR, Herberman RB. Natural killer activity in the rat II. Analysis of surface antigens on LGL by flow cytometry. J Immunol 1981;127:2204-8.
20. Vaage JT, Dissen E, Ager A, Fossum S, Rolstad B. Allospecific recognition of hemic cells in vitro by natural killer cells from athymic rats: evidence that allodeterminants coded for by single major histocompatibility complex haplotypes are recognized. Eur J Immunol 1991;21:2167-75.
21. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A. The ikaros gene is required for the development of all lymphoid lineages. Cell 1994;79:143-56.
22. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M, Georgopoulos K. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996;5:537-49.
23. Kägi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice [see comments]. Nature 1994;369:31-7.
24. Arase H, Arase N, Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995;181:1235-8.
25. Rouvier E, Luciani MF, Golstein P. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
26. Reynolds CW, Timonen T, Holden HT, Hansen CT, Herberman RB. Natural killer cell activity in the rat. Analysis of effector cell morphology and effects of interferon on natural killer cell function in the athymic (nude) rat. Eur J Immunol 1982;12:577-82.
27. Tutt MM, Kuziel WA, Hackett J Jr, Bennett M, Tucker PW, Kumar V. Murine natural killer cells do not express functional transcripts of the a-, b-, or t-chain genes of the T cell receptor. J Immunol 1986;137:2998-3001.
28. Tutt MM, Schuler W, Kuziel WA, Tucker PW, Bennett M, Bosma MJ, Kumar V. T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of SCID mice. J Immunol 1987;138:2338-44.
29. Lanier LL, Cwirla S, Federspiel N, Phillips JH. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor b chain genes. J Exp Med 1986;163:209-14.
30. Dissen E, Vaage JT, Tasken K, Jahnsen T, Rolstad B, Fossum S. Alloreactive lymphokine-activated killer cells from athymic nude rats do not express CD3-associated a/b or t/d T cell receptors. Int Immunol 1990;2:453-60.
31. Naume B, Espevik T. Immunoregulatory effects of cytokines on natural killer cells. Scand J Immunol 1994;40:128-34.
32. Perussia B. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol 1991;3:49-55.
33. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995;182:1045-56.
34. Maghazachi AA, Skålhegg BS, Rolstad B, Al-Aoukaty AS. Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J 1997; 765-74.
35. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 1991;173:1053-63.
36. Heslop BF. 1, Allogeneic lymphocyte cytotoxicity (ALC) in rats: allogeneic recognition vs. failed self recognition In: Rolstad B, ed. Natural Immunity to Normal Hemopoietic Cells. Boca Raton: CRC Press, Inc., 1994: 1-32.
37. Rolstad B, Wonigeit K, Vaage JT. 4, Alloreactive rat natural killer (NK) cells in vivo and in vitro: the role of the major histocompatibility complex (MHC). In: Rolstad B, ed. Natural Immunity to Normal Hemopoietic Cells. Boca Raton: CRC Press, Inc., 1994: 99-149.
38. Rolstad B, Ford WL. The rapid elimination of allogeneic lymphocytes: relationship to established mechanisms of immunity and to lymphocyte traffic. Immunol Rev 1983;73:87-113.
39. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990;172:1589-98.
40. Ljunggren H-G, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-44.
41. Kärre K, Ljunggren H-G, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675-8.
42. Parham P. NK cells, MHC class I antigens and missing self. Immunol Rev 1997:155.
43. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+IL-2-activated natural killer cells. Nature 1992;358:66-70.
44. Kane KP. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med 1994;179:1011-15.
45. Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM. A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 1994;180:687-92.
46. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993;11:613-35.
47. Takei F, Brennan J, Mager DL. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev 1997;155:67-77.
48. Höglund P, Sundbäck J, Olsson-Alheim MY, Johansson M, Salcedo M, Ohlen C, Ljunggren HG, Sentman CL, Karre K. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997;155:11-28.
49. George T, Yu YYL, Liu J, Davenport C, Lemieux S, Stoneman E, Mathew PA, Kumar V, Bennett M. Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone-marrow grafts. Immunol Rev 1997;155:29-40.
50. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997;155:41-52.
51. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997;155:53-65.
52. Ryan JC, Seaman WE. Divergent functions of lectin-like receptors on NK cells. Immunol Rev 1997;155:79-89.
53. Sentman CL, Olsson MY, Karre K. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self. Semin Immunol 1995;7:109-19.
54. Sentman CL, Olsson MY, Salcedo M, Höglund P, Lendahl U, Kärre K. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/ alpha 2 domains. J Immunol 1994;153:5482-90.
55. d restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A. J Immunol (in press).
56. Orihuela M, Margulies DH, Yokoyama WM. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc Natl Acad Sci USA 1996;93:11792-7.
57. Correa I, Raulet DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61-71.
58. Daniels BF, Nakamura MC, Rosen SD, Yokoyama WM, Seaman WE. Ly-49A, a receptor for H-2d, has a functional carbohydrate recognition domain. Immunity 1994;1:785-92.
59. Brennan J, Takei F, Wong S, Mager DL. Carbohydrate recognition by a natural killer cell receptor, Ly-49C. J Biol Chem 1995;270:9691-4.
60. Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F. Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J Exp Med 1996;183:1553-9.
61. Dissen E, Ryan JC, Seaman WE, Fossum S. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes. J Exp Med 1996;183:2197-207.
62. Naper C, Ryan JC, Nakamura MC, Lambracht D, Rolstad B, Vaage JT. Identification of an inhibitory MHC receptor on alloreactive rat NK cells. J Immunol 1998;160:219-24.
63. Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, Joly E, Butcher GW. Positive and negative MHC class I recognition by rat NK cells. Immunol Rev 1997;155:91-104.
64. Kraus E, Lambracht D, Wonigeit K, Hünig T. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition. Eur J Immunol 1996;26:2582-6.
65. Vaage JT, Naper C, Løvik G, Lambracht D, Rehm A, Hedrich HJ, Wonigeit K, Rolstad B. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens. J Exp Med 1994;180:641-51.
66. Naper C, Rolstad B, Wonigeit K, Butcher GW, Vaage JT. Genes in two MHC class I regions control recognition of a single rat natural killer cell allodeterminant. Int Immunol 1996;8:1779-85.
67. Wang C-R, Livingstone A, Butcher GW et al. Antigen presentation by neoclassical MHC class I gene products in murine rodents. In: Klein J, Klein D, eds. Molecular Evolution of the Major Histocompatibility Complex. NATO ASI Series, Vol. H 59. Berlin: Springer-Verlag, 1991: 441-62.
68. Günther E, Wurst W. Cytotoxic T lymphocytes of the rat are predominantly restricted by RT1.A- and not RT1.C-determined major histocompatibility class I antigens. Immunogenetics 1984;20:1-12.
69. Rolstad B, Naper C, Vaage JT. Natural killer (NK) cell recognition of MHC class I molecules. The Immunologist 1996; 4/5:165-72.
70. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sanchez-Mateos P, Sanchez-Madrid F. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal- transmitting receptors. J Exp Med 1993;178:537-47.
71. Long EO, Colonna M, Lanier LL. Inhibitory MHC class I receptors on NK and T cells: A standard nomenclature. Immunol Today 1996;17:100.
72. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-49.
73. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, Pantaleo G, Moretta L. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. J Exp Med 1990;171:695-714.
74. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, Mingari MC, Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997;155:105-17.
75. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994;180:537-43.
76. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997;155:145-54.
77. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, Accame L, Bottino C, Moretta A, Moretta L. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/ p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996;184:505-18.
78. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-8.
79. Ciccone E, Pende D, Viale O et al. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992;176:963-71.
80. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993;90:12000-4.
81. Döhring C, Colonna M. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur J Immunol 1996;26:365-9.
82. Reyburn H, Mandelboim O, Vales-Gomez M, Sheu EG, Pazmany L, Davis DM, Strominger JL. Human NK cells: their ligands, receptors and functions. Immunol Rev 1997;155:119-25.
83. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by 'Group 2' or 'Group 1' NK clones. J Exp Med 1995;182:605-9.
84. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:1133-44.
85. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol 1996;156:3098-101.
86. Rojo S, Burshtyn DN, Long EO, Wagtmann N. Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol 1997;158:9-12.
87. Wang LL, Mehta IK, LeBlanc PA, Yokoyama WM. Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J Immunol 1997;158:13-17.
88. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 1997;155:155-64.
89. Parham P. Events in the adaptation of natural killer cell receptors to MHC class I polymorphisms. Res Immunol 1997;148:190-4.
90. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 1995;155:2306-10.
91. Colonna M. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 1997;155:127-33.
92. Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, Wagtmann N, Winter CC. Killer cell inhibitory receptors: diversity, specificity, and function. Immunol Rev 1997;155:135-44.
93. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996;17:86-91.
94. Cella M, Döhring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997;185:1743-51.
95. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995;268:403-5.
96. Moretta A, Poggi A, Pende D, Tripodi G, Orengo A, Pella N, Augugliaro R, Bottino C, Ciccone E, Moretta L. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor a/b. J Exp Med 1991;174:1393-8.
97. De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994;180:1999-2004.
98. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433-7.
99. Lopez-Botet M, Perez-Villar JJ, Carretero M, Rodriguez A, Melero I, Bellon T, Llano M, Navarro F. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev 1997;155:165-74.
100. Perez-Villar JJ, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, Lopez-Botet M. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 1995;154:5779-88.
101. Phillips JH, Chang CW, Mattson J, Gumperz JE, Parham P, Lanier LL. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996;5:163-72.
102. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996;157:4741-5.
103. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 1997;158:3603-9.
104. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 1996;26:2487-92.
105. Braud VM, Allan DSJ, O'Callaghan CAO et al. HLA-E binds to natural-killer-cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-9.
106. Perez-Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, Colonna M, Geraghty DE, Lopez-Botet M. The CD94/NKG2A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997;158:5736-43.
107. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO. Peptide specificity in the recognition of MHC class I by natural killer cell clones [see comments]. Science 1995;267:1016-18.
108. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739-51.
109. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-63.
110. Timonen T, Ortaldo JR, Herberman RB. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 1981;153:569.
111. Shinkai Y, Rathbun G, Lam KP et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V (D) J rearrangement. Cell 1992;68:855-67.
112. Timonen T, Patarroyo M, Gahmberg CG. CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J Immunol 1988;141:1041-6.
113. Helander TS, Carpen O, Turunen O, Kovanen PE, Vaheri A, Timonen T. ICAM-2 redistributed by ezrin as a target for killer cells. Nature 1996;382:265-8.
114. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 1992;149:1115-23.
115. Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol 1991;147:3244-50.
116. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989;169:1373-89.
117. Arase H, Arase N, Saito T. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med 1996;183:2391-6.
118. Ryan JC, Niemi EC, Nakamura MC, Seaman WE. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med 1995;181:1911-15.
119. Mason LH, Anderson SK, Yokoyama WM, Smith HR, Winkler-Pickett R, Ortaldo JR. The Ly-49D receptor activates murine natural killer cells. J Exp Med 1996;184:2119-28.
120. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995;182:875-84.
121. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183:645-50.
122. Seaman WE, Eriksson E, Dobrow R, Imboden JB. Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX34: possible signaling role for the OX-34 determinant during activation by target cells. Proc Natl Acad Sci USA 1997;84:4239-43.
123. Einspahr KJ, Abraham RT, Binstadt BA, Uehara Y, Leibson PJ. Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc Natl Acad Sci USA 1991;88:6279-83.
124. Binstadt BA, Brumbaugh KM, Leibson PJ. Signal transduction by human NK cell MHC-recognizing receptors. Immunol Rev 1997;155:197-203.
125. Qian D, Weiss A. T cell antigen receptor signal transduction. Curr Opin Cell Biol 1997;9:205-12.
126. DeFranco AL. The complexity of signaling pathways activated by the BCR. Curr Opin Immunol 1997;9:296-308.
127. Biondi A, Paganin C, Rossi V, Benvestito S, Perlmutter RM, Mantovani A, Allavena P. Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells. Eur J Immunol 1991;21:843-6.
128. Bell GM, Bolen JB, Imboden JB. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol Cell Biol 1992;12:5548-54.
129. Olszowy MW, Leuchtmann PL, Veillette A, Shaw AS. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol 1995;155:4236-40.
130. Wen T, Zhang L, Kung SK, Molina TJ, Miller RG, Mak TW. Alloskin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck. Eur J Immunol 1995;25:3155-9.
131. van Oers NS, Lowin-Kropf B, Finlay D, Connolly K, Weiss A. Alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 1996;5:429-36.
132. Ostergaard HL, Shackclford DA, Hurley TR, Johnson P, Hyman R, Sefton BM, Trowbridge IS. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci USA 1989;86:8959-63.
133. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 1993;74:143-56.
134. Yamada H, Kishihara K, Kong YY, Nomoto K. Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6-deficient mice. J Immunol 1996;157:1523-8.
135. van Oers NS, Weiss A. The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes. Semin Immunol 1995;7:227-36.
136. Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, Parslow TG, Weiss A. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 1994;264:1599-601.
137. Negishi I, Motoyama N, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, Loh DY. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 1995;376:435-8.
138. Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995;378:303-6.
139. Siliciano JD, Morrow TA, Desiderio SV. Itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 1992;89:11194-8.
140. Teng JM, Liu XR, Mills GB, Dupont B. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C. J Immunol 1996;156:3222-32.
141. Liao XC, Fournier S, Killeen N, Weiss A, Allison JP, Littman DR. Itk negatively regulates induction of T cell proliferation by CD28 costimulation. J Exp Med 1997;186:221-8.
142. Liao XC, Littman DR. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 1995;3:757-69.
143. McVicar DW, Lal BK, Lloyd A, Kawamura M, Chen YQ, Zhang X, Staples JE, Ortaldo JR, O'Shea JJ. Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes. Oncogene 1994;9:2037-44.
144. Kawamura M, McVicar DW, Johnston JA, Blake TB, Chen YQ, Lal BK, Lloyd AR, Kelvin DJ, Staples JE, Ortaldo JR. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci USA 1994;91:6374-8.
145. Yu CR, Lin JX, Fink DW, Akira S, Bloom ET, Yamauchi A. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J Immunol 1996;157:126-37.
146. Nakamura MC, Niemi EC, Fisher MJ, Schultz LD, Seaman WE, Ryan JC. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phophatase. J Exp Med 1997;185:673-84.
147. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996;4:77-85.
148. Olcese L, Lang P, Vely F et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 1996;156:4531-4.
149. Valiante NM, Phillips JH, Lanier LL, Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp. 36/PLC-gamma signaling complex in human natural killer (NK) cells. J Exp Med 1996;184:2243-50.
150. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993;90:12000-4.
151. Unkeless JC, Jin J. Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol 1997;9:338-43.
152. Pei D, Wang J, Walsh CT. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proc Natl Acad Sci USA 1996;93:1141-5.
153. Renard V, Cambiaggi A, Vely F, Blery M, Olcese L, Olivero S, Bouchet M, Vivier E. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev 1997;155:205-21.
154. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996;5:629-38.
155. Tsui HW, Siminovitch KA, de Souza L, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet 1993;4:124-9.
156. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993;73:1445-54.
157. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 1997;158:5083-6.
158. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998;391:703-7.
159. Maghazachi AA, Al-Aoukaty AS, Naper C, Torgersen KM, Rolstad B. Preferential involvement of Go and Gz proteins in mediating rat Natural Killer cell lysis of allogeneic and tumor target cells. J Immunol 1996;157:5308-14.
160. Al-Aoukaty AS, Rolstad B, Maghazachi AA. Functional coupling of NKR-P1 receptors to various G proteins in rat IL-2 activated natural killer cells. J Biol Chem 1997;272:31604-8.
161. Torgersen KM, Vaage JT, Levy FO, Hansson V, Rolstad B, Taskén K. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J Biol Chem 1997;272:5495-500.
162. Bancroft GJ, Shellam GR, Chalmer JE. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 1981;126:988-94.
163. Bukowski JF, Warner JF, Dennert G, Welsh RM. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 1985;161:40-52.
164. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989;320:1731-5.
165. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993;5:503-10.
166. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo [see comments]. Nature 1997;386:510-14.
167. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells [see comments]. Nature 1997;386:514-17.
168. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 1992;149:581-9.
169. Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 1985;134:2783-9.
170. Barlozzari T, Herberman RB, Reynolds CW. Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes. Proc Natl Acad Sci USA 1987;84:7691-5.
171. Hansson M, Petersson M, Koo GC, Wigzell H, Kiessling R. In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen. Eur J Immunol 1988;18:485-8.
172. Bellone G, Valiante NM, Viale O, Ciccone E, Moretta L, Trinchieri G. Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones. J Exp Med 1993;177:1117-25.
173. Rolstad B. Role of the major histocompatibility complex class I regions in rat natural killer cell allograft responses in vivo and in vitro. Chem Immunol 1996;64:59-76.
174. Bennett M, Rembecki RM, Sentman CL et al. 2, Bone marrow transplantation and natural killer (NK) cells in mice. In: Rolstad B, ed. Natural Immunity to Normal Hemopoietic Cells. Boca Raton: CRC Press, Inc., 1994: 33-84.
175. Rolstad B, Vaage JT. The role of natural killer cells in allograft responses to MHC antigens in the rat. Res Immunol 1997;148:159-64.
176. Engh E, Benestad HB, Strøm-Gundersen I, Vaage JT, Bell EB, Rolstad B. The role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in NK cell mediated bone marrow allograft rejection in rats. Transplantation 1998;65:319-24.
177. Dissen E, Berg SF, Westgaard IH, Fossum S. Molecular characterization of a gene in the rat homologous to human CD94. Eur J Immunol 1997;27:2080-6.
178. Berg SF, Dissen E, Westgaard IH, Fossum S. Two genes in the rat homologous to human NKG2. Eur J Immunol 1998;28:444-50.
179. Weber JR, Ørstavik S, Torgersen KM et al. Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively expressed by T cells and natural killer cells. J Exp Med 1998 (in press).